Company Epigenomics AG Deutsche Boerse AG
Equities
ECX
DE000A11QW50
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.785 EUR | -1.92% | +9.51% | -4.03% |
Business Summary
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
In Vitro Diagnostic - Products
95.9
%
| 0 | 7.5 % | 0 | 95.9 % | -.--% |
Licensing
4.1
%
| 0 | 0.4 % | 0 | 4.1 % | -9.09% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
54.2
%
| 0 | 4.8 % | 0 | 54.2 % | -11.45% |
Europe
38.6
%
| 0 | 3.0 % | 0 | 38.6 % | -1.06% |
Asia
7.2
%
| 6 | 92.2 % | 0 | 7.2 % | -99.39% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 866,351 | 575,540 ( 66.43 %) | 0 | 66.43 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.65% | 12.14B | |
+82.29% | 3.94B | |
-14.23% | 2.32B | |
-23.73% | 2.19B | |
-19.45% | 1.63B | |
+32.37% | 1.14B | |
+7.42% | 852M | |
-11.75% | 545M | |
-34.49% | 419M |
- Stock
- Equities
- Stock Epigenomics AG
- Stock Epigenomics AG - Deutsche Boerse AG
- Company Epigenomics AG